Avella Specialty Pharmacy Recalls Sterile Products
Avella issued a nationwide recall of sterile products produced at the Advanced Pharma Houston location due to inaccurate labeling.
On Feb. 23, 2017, Advanced Pharma, Inc. d/b/a Avella of Houston announced it was voluntarily recalling all unexpired sterile injectable products because products labeled “latex free” may contain synthetic latex and/or natural latex. The recalled products were produced at the company’s Houston, TX location from Sept. 1, 2016–Feb. 16, 2017 and were distributed to healthcare facilities.
While it has not yet received any reports of adverse events, the company is recalling the products out of caution because it cannot be confirmed whether the “latex free” statement is accurate in all cases. According to the company, allergic reactions to latex may include swelling and inflammation and could be life threatening.
The company recommends healthcare facilities discontinue use of the products and return unused portions to Avella Specialty Pharmacy. Adverse events may be reported to FDA at the agency’s website.
Source: FDA
MHRA Approves GSK Therapy Combinations for Multiple Myeloma
April 21st 2025Belantamab mafodotin is approved in combination with bortezomib plus dexamethasone in patients who have had at least one prior therapy, and in combination with pomalidomide plus dexamethasone for those who have had a prior therapy including lenalidomide.
